HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xing-Quan Zhao Selected Research

Xing-Quan Zhao Research Topics

Disease

29Stroke (Strokes)
11/2023 - 10/2008
21Ischemic Stroke
11/2023 - 02/2012
7Atrial Fibrillation
02/2023 - 08/2010
6Transient Ischemic Attack
08/2021 - 10/2008
3Hypertension (High Blood Pressure)
02/2023 - 08/2021
3Cerebral Infarction
06/2022 - 10/2008
2Inflammation (Inflammations)
11/2023 - 06/2022
2Peripheral Vascular Diseases (Peripheral Vascular Disease)
02/2023 - 10/2022
2Deglutition Disorders (Dysphagia)
02/2023 - 01/2021
2Dyslipidemias (Dyslipidemia)
10/2022 - 08/2021
2Hematoma
07/2014 - 12/2012
2Cerebral Hemorrhage
06/2014 - 12/2012
1Infections
01/2023
1Hyperlipidemias (Hyperlipidemia)
01/2023
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2022
1Atherosclerotic Plaque (Atheroma)
06/2022
1Infarction (Infarctions)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
08/2021
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
08/2021
1Thromboembolism
01/2021
1Diabetes Mellitus
10/2019
1Proteinuria
09/2019
1Pathologic Constriction (Stenosis)
01/2016
1Anemia
07/2014
1Carotid Stenosis (Carotid Artery Stenosis)
12/2012
1Coronary Disease (Coronary Heart Disease)
03/2012

Drug/Important Bio-Agent (IBA)

7Tissue Plasminogen Activator (Alteplase)FDA Link
01/2023 - 01/2013
4Biomarkers (Surrogate Marker)IBA
11/2023 - 12/2012
4oxidized low density lipoproteinIBA
01/2023 - 12/2012
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2019 - 10/2008
3C-Reactive ProteinIBA
11/2023 - 03/2012
3Clopidogrel (Plavix)FDA Link
02/2023 - 01/2016
3AnticoagulantsIBA
02/2023 - 01/2021
3LDL CholesterolIBA
01/2023 - 08/2021
3LipidsIBA
01/2023 - 11/2014
2Interleukin-6 (Interleukin 6)IBA
11/2023 - 11/2023
2omega-Chloroacetophenone (Mace)IBA
09/2023 - 01/2023
2Warfarin (Coumadin)FDA LinkGeneric
01/2021 - 08/2010
2Glucose (Dextrose)FDA LinkGeneric
07/2014 - 03/2012
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
11/2023
1CytokinesIBA
11/2023
1Particulate MatterIBA
01/2023
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2022
1danaparoid (Orgaran)FDA Link
01/2022
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2021
1RivaroxabanIBA
01/2021
1DabigatranFDA Link
01/2021
1Phosphates (Orthophosphate)IBA
01/2021
1Vitamin KFDA Link
01/2021
1apixabanIBA
01/2021
1edoxabanIBA
01/2021
1AlbuminsIBA
01/2021
1CalciumIBA
01/2021
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2019
1Blood Glucose (Blood Sugar)IBA
09/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2016
1Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2015
1Yindan XinnaotongIBA
11/2014
1Antihypertensive Agents (Antihypertensives)IBA
02/2013
1MicroRNAs (MicroRNA)IBA
12/2012
1HomocysteineIBA
03/2012

Therapy/Procedure

11Therapeutics
11/2023 - 10/2008
8Secondary Prevention
11/2023 - 10/2008
2Length of Stay
02/2023 - 04/2021
1Treatment Delay
01/2023
1Time-to-Treatment
01/2022
1Stents
10/2008
1Contraindications
10/2008